Peidi Hu

1.3k total citations
21 papers, 1.1k citations indexed

About

Peidi Hu is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Peidi Hu has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Molecular Biology. Recurrent topics in Peidi Hu's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Peidi Hu is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Peidi Hu collaborates with scholars based in United States, Netherlands and Germany. Peidi Hu's co-authors include Patrick J. Sinko, Ailan Guo, Stanley J. Stein, Piyun Chao, Daniel A. Norris, Manjeet Deshmukh, Debra L. Laskin, Hilliard L. Kutscher, Praveen Balimane and Frederick H. Leibach and has published in prestigious journals such as American Journal of Public Health, Environmental Health Perspectives and Journal of Controlled Release.

In The Last Decade

Peidi Hu

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peidi Hu United States 16 387 292 214 190 143 21 1.1k
Brita Sjöström Sweden 13 340 0.9× 333 1.1× 283 1.3× 140 0.7× 80 0.6× 19 912
Manisha Ramaswamy Canada 19 304 0.8× 331 1.1× 145 0.7× 102 0.5× 292 2.0× 28 1.0k
Jason Zastre United States 21 327 0.8× 325 1.1× 166 0.8× 127 0.7× 268 1.9× 35 1.2k
Noha N. Salama United States 21 418 1.1× 432 1.5× 228 1.1× 79 0.4× 128 0.9× 41 1.5k
John M. Hilfinger United States 22 507 1.3× 641 2.2× 331 1.5× 113 0.6× 84 0.6× 44 1.5k
Rose Hayeshi South Africa 16 223 0.6× 269 0.9× 148 0.7× 83 0.4× 153 1.1× 31 892
Inge A.M. de Graaf Netherlands 24 651 1.7× 416 1.4× 113 0.5× 135 0.7× 79 0.6× 57 1.9k
Ryoko Yumoto Japan 25 887 2.3× 654 2.2× 303 1.4× 475 2.5× 139 1.0× 96 2.3k
Jonathan Cheong United States 13 412 1.1× 444 1.5× 151 0.7× 135 0.7× 31 0.2× 30 1.3k
Ahmad Y. Abuhelwa Australia 17 250 0.6× 240 0.8× 194 0.9× 65 0.3× 46 0.3× 65 1.1k

Countries citing papers authored by Peidi Hu

Since Specialization
Citations

This map shows the geographic impact of Peidi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peidi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peidi Hu more than expected).

Fields of papers citing papers by Peidi Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peidi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peidi Hu. The network helps show where Peidi Hu may publish in the future.

Co-authorship network of co-authors of Peidi Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Peidi Hu. A scholar is included among the top collaborators of Peidi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peidi Hu. Peidi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qiang, Yan Zhang, Jason Boer, et al.. (2017). In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions. Drug Metabolism and Disposition. 45(6). 612–623. 12 indexed citations
2.
Kutscher, Hilliard L., Piyun Chao, Manjeet Deshmukh, et al.. (2010). Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. Journal of Controlled Release. 143(1). 31–37. 92 indexed citations
3.
Yang, Haiming, et al.. (2010). Developmental morphology of the small intestine in Yangzhou goslings. AFRICAN JOURNAL OF BIOTECHNOLOGY. 9(43). 7392–7400. 15 indexed citations
4.
Kutscher, Hilliard L., Piyun Chao, Manjeet Deshmukh, et al.. (2010). Enhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats. International Journal of Pharmaceutics. 402(1-2). 64–71. 40 indexed citations
5.
Chao, Piyun, Manjeet Deshmukh, Hilliard L. Kutscher, et al.. (2009). Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model. Anti-Cancer Drugs. 21(1). 65–76. 58 indexed citations
6.
Usansky, Helen, Peidi Hu, & Patrick J. Sinko. (2008). Differential Roles of P-Glycoprotein, Multidrug Resistance-Associated Protein 2, and CYP3A on Saquinavir Oral Absorption in Sprague-Dawley Rats. Drug Metabolism and Disposition. 36(5). 863–869. 28 indexed citations
7.
8.
Su, Yaming, et al.. (2007). Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan. Journal of Pharmacy & Pharmaceutical Sciences. 10(4). 519–519. 30 indexed citations
9.
Lalloo, Anita, Piyun Chao, Peidi Hu, Stanley J. Stein, & Patrick J. Sinko. (2006). Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins. Journal of Controlled Release. 112(3). 333–342. 69 indexed citations
11.
Sinko, Patrick J., Yong‐Hee Lee, Glen Leesman, et al.. (1999). Biopharmaceutical Approaches for Developing and Assessing Oral Peptide Delivery Strategies and Systems: In Vitro Permeability and In Vivo Oral Absorption of Salmon Calcitonin. Pharmaceutical Research. 16(4). 527–533. 59 indexed citations
12.
Guo, Ailan, Peidi Hu, Praveen Balimane, Frederick H. Leibach, & Patrick J. Sinko. (1999). Interactions of a Nonpeptidic Drug, Valacyclovir, with the Human Intestinal Peptide Transporter (hPEPT1) Expressed in a Mammalian Cell Line. Journal of Pharmacology and Experimental Therapeutics. 289(1). 448–454. 81 indexed citations
13.
Guo, Ailan, et al.. (1998). Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells. Pharmaceutical Research. 15(8). 1160–1167. 185 indexed citations
14.
Sinko, Patrick J., John P. Sutyak, Glen Leesman, et al.. (1997). Oral absorption of anti- AIDS nucleoside analogues. 3. Regional absorption andin vivo permeability of 2′, 3′ - dideoxyinosine in an intestinal-vascular access port (IVAP) dog model. Biopharmaceutics & Drug Disposition. 18(8). 697–710. 10 indexed citations
15.
Sinko, Patrick J. & Peidi Hu. (1996). Determining Intestinal Metabolism and Permeability for Several Compounds in Rats. Implications on Regional Bioavailability in Humans. Pharmaceutical Research. 13(1). 108–113. 9 indexed citations
16.
Sinko, Patrick J., et al.. (1995). Oral absorption of anti-aids nucleoside analogues. 1. Intestinal transport of didanosine in rat and rabbit preparations. Journal of Pharmaceutical Sciences. 84(8). 959–965. 38 indexed citations
17.
Vine, M F, B Hulka, Barry H. Margolin, et al.. (1993). Cotinine concentrations in semen, urine, and blood of smokers and nonsmokers.. American Journal of Public Health. 83(9). 1335–1338. 99 indexed citations
18.
19.
Hu, Peidi, et al.. (1990). Interactive inhibition of erythroid 59Fe utilization by benzene metabolites in female mice. Chemico-Biological Interactions. 74(1-2). 55–62. 26 indexed citations
20.
Snyder, Robert, et al.. (1989). Studies on the mechanism of benzene toxicity.. Environmental Health Perspectives. 82. 31–35. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026